We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+13.06%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$8.1B
AUM Growth
+$4.9B
Cap. Flow
+$4.22B
Cap. Flow %
52.11%
Top 10 Hldgs %
26.76%
Holding
6,444
New
505
Increased
3,426
Reduced
1,637
Closed
524

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$314M
2
AAPL icon
Apple
AAPL
+$247M
3
MSFT icon
Microsoft
MSFT
+$235M
4
AMZN icon
Amazon
AMZN
+$110M
5
NVDA icon
NVIDIA
NVDA
+$99M

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$21.7M
2
VNQ icon
Vanguard Real Estate ETF
VNQ
+$13.8M
3
SPLV icon
Invesco S&P 500 Low Volatility ETF
SPLV
+$12.8M
4
USO icon
United States Oil Fund
USO
+$12.5M
5
IBB icon
iShares Biotechnology ETF
IBB
+$12M

Sector Composition

Rank Sector Weight
1 Technology 26.14%
2 Financials 11.29%
3 Healthcare 10.69%
4 Consumer Discretionary 10.28%
5 Industrials 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LPTH icon
4276
Lightpath Technologies
LPTH
$824M
$10.2K ﹤0.01%
8,116
+3,072
+61% +$4.23K
NXGL icon
4277
NexGel
NXGL
$4.51M
$10.2K ﹤0.01%
4,799
+1,999
+71% +$3.86K
CLRB icon
4278
Cellectar Biosciences
CLRB
$19.8M
$10.2K ﹤0.01%
123
-76
-38% -$5.66K
PRTH icon
4279
Priority Technology Holdings
PRTH
$458M
$10.2K ﹤0.01%
2,867
-6,222
-68% -$20.9K
AWRE icon
4280
Aware
AWRE
$26.4M
$10.2K ﹤0.01%
6,144
+611
+11% +$915
IBB icon
4281
iShares Biotechnology ETF
IBB
$9.77B
$10.2K ﹤0.01%
75
-98,477
-100% -$12M
FVCB icon
4282
FVCBankcorp
FVCB
$339M
$10.2K ﹤0.01%
716
-2,977
-81% -$36.1K
SONM icon
4283
DNA X Inc
SONM
$5.05M
$10.2K ﹤0.01%
77
+6
+8% +$796
VOXX
4284
DELISTED
VOXX International Corporation Class A
VOXX
$10.2K ﹤0.01%
951
-1,312
-58% -$13K
PYXS icon
4285
Pyxis Oncology
PYXS
$191M
$10.2K ﹤0.01%
5,639
+3,656
+184% +$6.26K
ELDN icon
4286
Eledon Pharmaceuticals
ELDN
$286M
$10.1K ﹤0.01%
5,636
-2,807
-33% -$3.9K
DUOT icon
4287
Duos Technologies
DUOT
$294M
$10.1K ﹤0.01%
3,497
+1,357
+63% +$4.77K
RLMD icon
4288
Relmada Therapeutics
RLMD
$507M
$10.1K ﹤0.01%
2,449
+739
+43% +$2.19K
SOTK icon
4289
Sono-Tek
SOTK
$81.1M
$10.1K ﹤0.01%
1,873
+1,060
+130% +$5.44K
TRVI icon
4290
Trevi Therapeutics
TRVI
$2.59B
$10.1K ﹤0.01%
7,557
+1,104
+17% +$1.67K
INUV icon
4291
Inuvo
INUV
$14.2M
$10.1K ﹤0.01%
2,379
-721
-23% -$1.88K
MLP icon
4292
Maui Land & Pineapple Co
MLP
$310M
$10.1K ﹤0.01%
636
-932
-59% -$13.7K
ABEO icon
4293
Abeona Therapeutics
ABEO
$361M
$10.1K ﹤0.01%
2,014
-8,307
-80% -$36.5K
SILO icon
4294
Silo Pharma
SILO
$4.03M
$10.1K ﹤0.01%
467
+141
+43% +$3.2K
CPIX icon
4295
Cumberland Pharmaceuticals
CPIX
$118M
$10.1K ﹤0.01%
5,628
+596
+12% +$1.09K
ASPI icon
4296
ASP Isotopes
ASPI
$539M
$10.1K ﹤0.01%
5,632
-6,192
-52% -$9.03K
LANV icon
4297
Lanvin Group Holdings
LANV
$130M
$10.1K ﹤0.01%
3,417
+428
+14% +$1.5K
NPCT icon
4298
Nuveen Core Plus Impact Fund
NPCT
$284M
$10.1K ﹤0.01%
1,000
-58
-5% -$551
ESSA
4299
DELISTED
ESSA Bancorp
ESSA
$10.1K ﹤0.01%
503
-836
-62% -$14K
SCTL
4300
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$10.1K ﹤0.01%
28,680
+6,622
+30% +$2.42K
170 171
172
173 174

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2023 Portfolio in Review

As of Q4 2023, Tower Research Capital (TRC) held 6,444 positions worth $8.1B, up 153% from $3.2B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $4.22B of net new capital in Q4 2023, opening 505 new positions and adding to 3,426 existing holdings. Its largest new stake was Veralto: 28,523 shares worth $2.35M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $21.7M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2023 buy was Veralto: 28,523 shares worth $2.35M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $314M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2023 reduction was iShares MSCI EAFE ETF, cutting an estimated $21.7M.
  • Tower Research Capital (TRC) fully exited Vanguard Morningstar Total Stock Market ETF in Q4 2023, selling an estimated $6.02M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $8.1B portfolio in Q4 2023.
  • Tower Research Capital (TRC) opened 505 new positions and closed 524 in Q4 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 153% quarter-over-quarter to $8.1B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.